MYCOBACTERIUM KANSASII LUNG INFECTIONS COMPARED TO OTHER NONTUBERCULOUS MYCOBACTERIA

S. Pedrero Tejada (Barakaldo, Spain), E. Tabernero Huguet (Barakaldo, Spain), B. Ortiz De Urbina Antia (Barakaldo, Spain), I. Salinas Garrido (Barakaldo, Spain), B. Gonzalez Quero (Barakaldo, Spain), E. Arana Arri (Barakaldo, Spain), E. Urra Zalbidegoitia (Barakaldo, Spain), R. Zalacain Jorge (Barakaldo, Spain)

Source: International Congress 2018 – Difficult-to-treat respiratory infections
Session: Difficult-to-treat respiratory infections
Session type: Thematic Poster
Number: 4718
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Pedrero Tejada (Barakaldo, Spain), E. Tabernero Huguet (Barakaldo, Spain), B. Ortiz De Urbina Antia (Barakaldo, Spain), I. Salinas Garrido (Barakaldo, Spain), B. Gonzalez Quero (Barakaldo, Spain), E. Arana Arri (Barakaldo, Spain), E. Urra Zalbidegoitia (Barakaldo, Spain), R. Zalacain Jorge (Barakaldo, Spain). MYCOBACTERIUM KANSASII LUNG INFECTIONS COMPARED TO OTHER NONTUBERCULOUS MYCOBACTERIA. 4718

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CHARACTERIZATION OF ACELLULAR LUNG SCAFFOLDS DERIVED FROM EQUINE ASTHMA MODEL
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019

DISCREPANCY ACROSS PHENOTYPIC AND GENOTYPIC RESULTS OF DRUG SUSCEPTIBILITY TESTING OF MYCOBACTERIUM TUBERCULOSIS
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



IDENTIFICATION OF A DISTINCT EOSINOPHIL SUBPOPULATION IN INDUCED SPUTUM FROM ATOPIC ASTHMATICS
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018


PREVALENCE OF SENSITIZATION TO AVIAN OR FUNGAL PROTEINS IN DIFFERENT WORK ENVIRONMENTS.
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018

TRANSCRIPTOMIC PROFILING REVEALS M1-HIGH TUMOUR ASSOCIATED MACROPHAGES THAT ORCHESTRATE THE ADAPTIVE ANTI-TUMOUR RESPONSE IN HUMAN LUNG CANCER
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017

OSTEOPONTIN PROTECTS AGAINST LUNG INJURY CAUSED BY EXTRACELLULAR HISTONES
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018

MACROLIDE RESISTANCE HAS A PROGNOSTIC IMPACT IN BACTEREMIC PNEUMOCOCCAL PNEUMONIA
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


NONTUBERCULOUS MYCOBACTERIA IN BRONCHIECTASIS: PREVALENCE AND PATIENT CHARACTERISTICS.
Source: Eur Respir J 2007; 29: 614-615
Year: 2007


PERINATAL INFLAMMATION AND INTRAUTERINE GROWTH RETARDATION ARE BOTH ASSOCIATED WITH LUNG FUNCTION IMPAIRMENT AT 12 YEARS OF AGE IN VERY PRETERM INFANTS
Source: International Congress 2018 – Assessing pathophysiology in children
Year: 2018

EFFECT OF CHLORHEXIDINE BATH ON THE PREVENTION OF VENTILATOR ASSOCIATED PNEUMONIA: A META-ANALYSIS
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019

FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


CELL DEATH MODES OF WHITE BLOOD CELLS IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA AND PULMONARY TUBERCULOSIS
Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection
Year: 2021


EFFICACY OF IRON REPLETION WITHOUT ERYTHROPOIESIS-STIMULATING AGENT IN PATIENTS WITHCHEMOTHERAPY-INDUCED ANEMIA IN LUNG CANCER
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018


EFFECTS OF AEROBIC AND BREATHING EXERCISES ON CLINICAL CONTROL AND AIRWAY INFLAMMATION IN PERSISTENT ASTHMA
Source: International Congress 2017 – Exercise training and breathing exercises in chronic respiratory disease
Year: 2017



BRONCHIOLITIS ASSOCIATED WITH VIRAL COINFECTIONS AND ASTHMA DEVELOPMENT
Source: International Congress 2017 – Pulmonary infection and inflammation
Year: 2017


PURINERGIC SIGNALING AND LYMPHOID ORGANS ARE INVOLVED IN THE BENEFICIAL EFFECTS OF AEROBIC TRAINING IN ASTHMA
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


THE IMPACT OF REFLEXOLOGY AND HOMEOPATHY ADDED TO CONVENTIONAL ASTHMA TREATMENT ON MARKERS OF AIRWAY INFLAMMATION– A RANDOMISED STUDY
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019

TWO WEEKS OF INTERMITTENT HYPOXIC EXPOSURE INDUCE LIPOLYSIS AT THE FAT TISSUE LEVEL IN HEALTHY HUMAN SUBJECTS.
Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Year: 2017